Press releases & Media

Press releases

• A3P Biomedical appoints Andreas Hoel as new VP of Marketing & Sales
  November 1, 2022
• Zürich University Hospital starts using Stockholm3
  October 31, 2022
• The European Commission recommends member states to implement organized screening of prostate cancer
  September 26, 2022

More press releases

A3P in media

• Stena Sessan, EQT founder Thomas von Koch and one of Sweden’s leading life science investors invest in A3P Biomedical.
  May 6, 2022
• Finally time for public screening of prostate cancer? (In Swedish)
  November 22, 2021
• Stockholm3, in combination with MRI, make general screening of prostate cancer possible (in Swedish)
  October 6, 2021

More articles